// App-Quantinova.ai

1091 : Multi-institutional study of triple negative breast cancer stratification by a metric that quantifies cell cycling kinetics.

Researchers

Presenter

  • Sergey Klimov

Principal Investigators

  • Guanhao Wei

  • Andrew R. Green

  • Mohammed Aleskandarany

  • Emad Rakha

  • Ian O. Ellis

  • Guilherme Henrique Cantuaria

  • Ayodeji Agboola

  • Michelle D. Reid

  • Xiaoxian Li

  • Padmashree C.G. Rida

  • Remus Osan

  • Ritu Aneja

Medical Centers

  • Georgia State University, Atlanta, GA

  • Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom

  • University of Nottingham, Nottingham, United Kingdom

  • Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom

  • Division of Pathology, Nottingham University Hospitals, Nottingham, United Kingdom

  • Northside Hospital, Atlanta, GA

  • Olabisi Onabanjo University, Ogun State., Nigeria

  • Emory University School of Medicine, Atlanta, GA

Locations

  • United States

  • United Kingdom

  • Nigeria

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Proliferation marker protein Ki-67

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved